This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Pyritinol
A semi-synthetic vitamin B6 derivative (Encephabol) consisting of two pyridoxine molecules bonded by a disulphide bridge - enhancing cholinergic neurotransmission, increasing cerebral glucose uptake, and improving blood flow to the brain, with clinical use for cognitive decline and learning difficulties across many countries.
Benefits
What is Pyritinol?
Pyritinol (pyridoxine disulphide, marketed as Encephabol) is a semi-synthetic compound created by bonding two molecules of pyridoxine (vitamin B6) via a disulphide bridge. Developed by Merck in the 1960s, it was one of the first synthetic nootropics to achieve widespread clinical use, and it remains a prescription or over-the-counter medication in numerous countries across Europe, Asia, and Latin America for the treatment of cognitive decline, dementia, and learning difficulties in children. Despite its structural relationship to vitamin B6, pyritinol does not function as a vitamin - its pharmacological profile is entirely distinct, with mechanisms centred on cholinergic enhancement, cerebral metabolic activation, and neuroprotection.
Clinical evidence for pyritinol's cognitive effects spans several decades. A randomised controlled trial published in Human Psychopharmacology (1993) by Hindmarch et al. demonstrated that 600 mg of pyritinol significantly improved reaction time and information processing in elderly subjects compared to placebo. A systematic review by Kessler et al. in Mechanisms of Ageing and Development (2010) found consistent evidence for improved attention, vigilance, and memory across multiple trials in both cognitively impaired and healthy populations. In paediatric neurology, pyritinol has been used clinically for decades to support cognitive development in children with learning difficulties, attention deficits, and perinatal brain injury. The compound increases cerebral glucose uptake by up to 40% (as measured by PET studies), enhances cholinergic transmission, improves cerebral blood flow, and provides antioxidant neuroprotection through its free radical scavenging properties.
- Cholinergic enhancement: Increases acetylcholine synthesis and release in the cortex and hippocampus by enhancing choline uptake and stimulating choline acetyltransferase activity, supporting memory formation and attentional processes
- Cerebral glucose metabolism: Increases glucose uptake and utilisation in the brain by up to 40%, providing additional metabolic fuel for energy-demanding cognitive processes including sustained attention and working memory
- Cerebral blood flow improvement: Enhances regional cerebral blood flow, ensuring adequate delivery of oxygen and nutrients to metabolically active brain regions during cognitive tasks
- Antioxidant neuroprotection: The disulphide bridge structure provides direct free radical scavenging activity, while also supporting glutathione recycling and reducing lipid peroxidation in neuronal membranes
- Phospholipid metabolism: Supports the synthesis and turnover of membrane phospholipids, maintaining neuronal membrane fluidity and integrity essential for receptor function and signal transduction
- Standard adult dose: 200 mg three times daily (600 mg total), the most commonly used dosage in clinical trials and prescribing guidelines
- Cognitive enhancement: 200-400 mg per day may be sufficient for nootropic purposes in healthy individuals, taken in divided doses
- Paediatric use (clinical): 100-200 mg per day for children, typically prescribed as the liquid Encephabol suspension under medical supervision
- Elderly/dementia support: 600 mg per day in divided doses, with clinical benefits typically emerging after 4-8 weeks of consistent use
- Timing: Take with meals to reduce the likelihood of gastrointestinal side effects. Divide the daily dose evenly across meals
- Generally well tolerated: Most clinical trials report a favourable safety profile comparable to placebo, with mild and transient side effects including nausea, headache, and sleep disturbances
- Rare hepatotoxicity: Post-marketing surveillance has identified rare cases of cholestatic hepatitis and acute hepatic failure. Liver function should be monitored during extended use, and the drug should be discontinued immediately if jaundice or elevated liver enzymes appear
- Autoimmune reactions: Rare cases of drug-induced pemphigus and other autoimmune skin reactions have been reported. Discontinue use if unexplained skin blistering or rash develops
- Drug interactions: May potentiate the effects of D-penicillamine and gold salts (used in rheumatoid arthritis), increasing the risk of autoimmune side effects. Use caution with hepatotoxic medications
- Contraindications: Not recommended for individuals with severe hepatic impairment, autoimmune disorders (particularly pemphigus), or known hypersensitivity to pyridoxine derivatives
Natural Sources & Forms
- Encephabol (Merck): The original branded product, available as 100 mg and 200 mg coated tablets and as an oral suspension (80 mg/5 mL) in many countries
- Generic pyritinol: Available as pyritinol hydrochloride tablets from various manufacturers in countries where it is approved
- Over-the-counter availability: Sold without prescription in some countries (Germany, Portugal, Brazil) and by prescription in others
- Online vendors: Available from international pharmacies and nootropic suppliers in countries where it is not locally marketed
Frequently Asked Questions
A semi-synthetic vitamin B6 derivative (Encephabol) consisting of two pyridoxine molecules bonded by a disulphide bridge - enhancing cholinergic neurotransmission, increasing cerebral glucose uptake, and improving blood flow to the brain, with clinical use for cognitive decline and learning difficulties across many countries.
The key benefits of Pyritinol include: Cognitive Enhancement, Energy, Focus, Longevity, Memory, Mood.
Cholinergic enhancement: Increases acetylcholine synthesis and release in the cortex and hippocampus by enhancing choline uptake and stimulating choline acetyltransferase activity, supporting memory formation and attentional processes Cerebral glucose metabolism: Increases glucose uptake and utilisation in the brain by up to 40%, providing additional metabolic fuel for energy-demanding cognitive processes including sustained attention and working memory Cerebral blood flow improvement: Enhances regional cerebral blood flow, ensuring adequate delivery of oxygen and nutrients to metabolically active brain regions during cognitive tasks Antioxidant neuroprotection: The disulphide bridge structure provides direct free radical scavenging activity, while also supporting glutathione recycling and reducing lipid peroxidation in neuronal membranes Phospholipid metabolism: Supports the synthesis and turnover of membrane phospholipids, maintaining neuronal membrane fluidity and integrity essential for receptor function and signal transduction
Standard adult dose: 200 mg three times daily (600 mg total), the most commonly used dosage in clinical trials and prescribing guidelines Cognitive enhancement: 200-400 mg per day may be sufficient for nootropic purposes in healthy individuals, taken in divided doses Paediatric use (clinical): 100-200 mg per day for children, typically prescribed as the liquid Encephabol suspension under medical supervision Elderly/dementia support: 600 mg per day in divided doses, with clinical benefits typically emerging after 4-8 weeks of consistent use Timing: Take with meals to reduce the likelihood of gastrointestinal side effects. Divide the daily dose evenly across meals
Generally well tolerated: Most clinical trials report a favourable safety profile comparable to placebo, with mild and transient side effects including nausea, headache, and sleep disturbances Rare hepatotoxicity: Post-marketing surveillance has identified rare cases of cholestatic hepatitis and acute hepatic failure. Liver function should be monitored during extended use, and the drug should be discontinued immediately if jaundice or elevated liver enzymes appear Autoimmune reactions: Rare cases of drug-induced pemphigus and other autoimmune skin reactions have been reported. Discontinue use if unexplained skin blistering or rash develops Drug interactions: May potentiate the effects of D-penicillamine and gold salts (used in rheumatoid arthritis), increasing the risk of autoimmune side effects. Use caution with hepatotoxic medications Contraindications: Not recommended for individuals with severe hepatic impairment, autoimmune disorders (particularly pemphigus), or known hypersensitivity to pyridoxine derivatives
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!